| scholarly article | Q13442814 |
| P2093 | author name string | Stella E Tsirka | |
| John K Robinson | |||
| Luisa Torres | |||
| Noreen Bukhari | |||
| P2860 | cites work | The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury | Q28191612 |
| Regeneration of adult axons in white matter tracts of the central nervous system | Q28257832 | ||
| NeuriteTracer: a novel ImageJ plugin for automated quantification of neurite outgrowth | Q28364771 | ||
| Changes in distribution, cell associations, and protein expression levels of NG2, neurocan, phosphacan, brevican, versican V2, and tenascin-C during acute to chronic maturation of spinal cord scar tissue | Q28566378 | ||
| Multiple regions of the NG2 proteoglycan inhibit neurite growth and induce growth cone collapse | Q28572393 | ||
| Chondroitinase ABC promotes functional recovery after spinal cord injury | Q29615017 | ||
| Chondroitin-4-sulfation negatively regulates axonal guidance and growth | Q30483928 | ||
| Adult NG2+ cells are permissive to neurite outgrowth and stabilize sensory axons during macrophage-induced axonal dieback after spinal cord injury | Q30493169 | ||
| Microtubule stabilization reduces scarring and causes axon regeneration after spinal cord injury | Q30513561 | ||
| Structural characterization of the epitopes of the monoclonal antibodies 473HD, CS-56, and MO-225 specific for chondroitin sulfate D-type using the oligosaccharide library. | Q33210460 | ||
| Analysis of axonal regeneration in the central and peripheral nervous systems of the NG2-deficient mouse | Q33300598 | ||
| The plasminogen (fibrinolytic) system | Q33799992 | ||
| In vivo imaging of axonal degeneration and regeneration in the injured spinal cord | Q34410369 | ||
| Chondroitin sulphate proteoglycans in the CNS injury response | Q35002812 | ||
| Sensory afferents regenerated into dorsal columns after spinal cord injury remain in a chronic pathophysiological state | Q35012930 | ||
| The tissue plasminogen activator (tPA)/plasmin extracellular proteolytic system regulates seizure-induced hippocampal mossy fiber outgrowth through a proteoglycan substrate | Q36326299 | ||
| The primary structure of NG2, a novel membrane-spanning proteoglycan | Q36530061 | ||
| Chondroitinase ABC-mediated plasticity of spinal sensory function | Q37352467 | ||
| tPA-mediated generation of plasmin is catalyzed by the proteoglycan NG2. | Q37492517 | ||
| Role of plasminogen activator in spinal cord remodeling after spinal cord injury | Q37570790 | ||
| Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC. | Q38524950 | ||
| Inhibiting glycosaminoglycan chain polymerization decreases the inhibitory activity of astrocyte-derived chondroitin sulfate proteoglycans | Q40030617 | ||
| Decorin suppresses neurocan, brevican, phosphacan and NG2 expression and promotes axon growth across adult rat spinal cord injuries | Q40525427 | ||
| An inhibitor of neurite outgrowth produced by astrocytes. | Q41464879 | ||
| Inhibitory effects of brain chondroitin sulfate proteoglycans on neurite outgrowth from PC12D cells | Q41692170 | ||
| Chondroitinase ABC promotes sprouting of intact and injured spinal systems after spinal cord injury. | Q42140143 | ||
| Amiloride selectively inhibits the urokinase-type plasminogen activator | Q42208028 | ||
| Tissue plasminogen activator mediates microglial activation via its finger domain through annexin II. | Q43972707 | ||
| Decreased neural damage after spinal cord injury in tPA-deficient mice | Q44340136 | ||
| Regulation of RPTPbeta/phosphacan expression and glycosaminoglycan epitopes in injured brain and cytokine-treated glia. | Q44707559 | ||
| Stem cells downregulate the elevated levels of tissue plasminogen activator in rats after spinal cord injury | Q46158053 | ||
| NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors. | Q46345563 | ||
| Bovine CNS myelin contains neurite growth-inhibitory activity associated with chondroitin sulfate proteoglycans | Q48093854 | ||
| Tissue plasminogen activator promotes axonal outgrowth on CNS myelin after conditioned injury. | Q51818638 | ||
| Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. | Q52051559 | ||
| Decorin promotes plasminogen/plasmin expression within acute spinal cord injuries and by adult microglia in vitro. | Q54606892 | ||
| Reduction of neurite outgrowth in a model of glial scarring following CNS injury is correlated with the expression of inhibitory molecules on reactive astrocytes | Q67703308 | ||
| An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus | Q71954963 | ||
| Inhibition of neurite growth by the NG2 chondroitin sulfate proteoglycan | Q72896530 | ||
| Upregulation of neurotoxic serine proteases, prothrombin, and protease-activated receptor 1 early after spinal cord injury | Q73458205 | ||
| Chondroitinase ABC promotes axonal regeneration of Clarke's neurons after spinal cord injury | Q73735755 | ||
| Chondroitinase ABCI improves locomotion and bladder function following contusion injury of the rat spinal cord | Q81411427 | ||
| Antibodies against the NG2 proteoglycan promote the regeneration of sensory axons within the dorsal columns of the spinal cord | Q83282931 | ||
| Plasminogen activator induction facilitates recovery of respiratory function following spinal cord injury | Q94608591 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 42 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | plasminogen | Q107129060 |
| P1104 | number of pages | 13 | |
| P304 | page(s) | 14931-14943 | |
| P577 | publication date | 2011-10-01 | |
| P1433 | published in | Journal of Neuroscience | Q1709864 |
| P1476 | title | Axonal regrowth after spinal cord injury via chondroitinase and the tissue plasminogen activator (tPA)/plasmin system | |
| P478 | volume | 31 |
| Q38770884 | ADAMTS-4 in central nervous system pathologies |
| Q37249700 | Alterations in sulfated chondroitin glycosaminoglycans following controlled cortical impact injury in mice |
| Q28571230 | Arylsulfatase B modulates neurite outgrowth via astrocyte chondroitin-4-sulfate: dysregulation by ethanol |
| Q37718952 | Astrocytic and vascular remodeling in the injured adult rat spinal cord after chondroitinase ABC treatment |
| Q33738641 | Chondroitin sulfate proteoglycans: structure-function relationship with implication in neural development and brain disorders |
| Q40419695 | Combined chondroitinase and KLF7 expression reduce net retraction of sensory and CST axons from sites of spinal injury |
| Q38234093 | Designing drugs that encourage spinal cord injury healing |
| Q38795175 | Dynamic microglial modulation of spatial learning and social behavior |
| Q45168459 | Effects of an immunomodulatory therapy and chondroitinase after spinal cord hemisection injury |
| Q34414830 | Examination of the combined effects of chondroitinase ABC, growth factors and locomotor training following compressive spinal cord injury on neuroanatomical plasticity and kinematics |
| Q34566967 | Extracellular matrix-associated gene expression in adult sensory neuron populations cultured on a laminin substrate. |
| Q30542858 | Intraventricular hemorrhage induces deposition of proteoglycans in premature rabbits, but their in vivo degradation with chondroitinase does not restore myelination, ventricle size and neurological recovery |
| Q33898347 | Kallikrein cascades in traumatic spinal cord injury: in vitro evidence for roles in axonopathy and neuron degeneration |
| Q37333802 | LRP1 assembles unique co-receptor systems to initiate cell signaling in response to tissue-type plasminogen activator and myelin-associated glycoprotein. |
| Q37744900 | Lack of collagen XV is protective after ischemic stroke in mice. |
| Q37229269 | Lectican proteoglycans, their cleaving metalloproteinases, and plasticity in the central nervous system extracellular microenvironment |
| Q41831282 | Microglial inhibitory factor (MIF/TKP) mitigates secondary damage following spinal cord injury |
| Q38246350 | Molecular mechanisms of scar-sourced axon growth inhibitors |
| Q36955808 | Nerve regeneration restores supraspinal control of bladder function after complete spinal cord injury. |
| Q39007151 | Nicotinic regulation of experience-dependent plasticity in visual cortex. |
| Q26777276 | Physiological and pathological roles of tissue plasminogen activator and its inhibitor neuroserpin in the nervous system |
| Q89371335 | Pifithrin-μ modulates microglial activation and promotes histological recovery following spinal cord injury |
| Q48392806 | Plasminogen activator inhibitor-1 promotes synaptogenesis and protects against aβ(1-42)-induced neurotoxicity in primary cultured hippocampal neurons |
| Q89049343 | Plasminogen activator system homeostasis and its dysregulation by ethanol in astrocyte cultures and the developing brain |
| Q93162167 | Protease-independent action of tissue plasminogen activator in brain plasticity and neurological recovery after ischemic stroke |
| Q38222632 | Scar-modulating treatments for central nervous system injury |
| Q91130333 | Short-term inhibition of fibrinolytic system restores locomotor function after spinal cord injury in mice |
| Q28542725 | Subacute intranasal administration of tissue plasminogen activator promotes neuroplasticity and improves functional recovery following traumatic brain injury in rats |
| Q48614461 | The Role of TLR4 and Fyn Interaction on Lipopolysaccharide-Stimulated PAI-1 Expression in Astrocytes |
| Q40532626 | Tissue Plasminogen Activator Expression Is Restricted to Subsets of Excitatory Pyramidal Glutamatergic Neurons |
| Q37042958 | Tissue plasminogen activator contributes to morphine tolerance and induces mechanical allodynia via astrocytic IL-1β and ERK signaling in the spinal cord of mice |
| Q30667273 | Tissue plasminogen activator inhibits NMDA-receptor-mediated increases in calcium levels in cultured hippocampal neurons |
| Q30836172 | Tissue-type plasminogen activator controls neuronal death by raising surface dynamics of extrasynaptic NMDA receptors. |
| Q31057328 | Tuftsin promotes an anti-inflammatory switch and attenuates symptoms in experimental autoimmune encephalomyelitis |
| Q36064401 | Unmasking Proteolytic Activity for Adult Visual Cortex Plasticity by the Removal of Lynx1 |
| Q48140296 | Urokinase-type plasminogen activator modulates mammalian circadian clock phase regulation in tissue-type plasminogen activator knockout mice |
| Q28581097 | Valproic acid induces astrocyte-dependent neurite outgrowth from cultured rat primary cortical neuron via modulation of tPA/PAI-1 activity |
| Q45902163 | tPA regulates neurite outgrowth by phosphorylation of LRP5/6 in neural progenitor cells. |
Search more.